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Once almost universally fatal, severe combined immuno-
deficiency (SCID) is now treated with hematopoietic
stem cell transplantation, which allows many children to
survive. Because the transplants are not always successful,
the Primary Immune Deficiency Treatment Consortium
was formed to share information and identify factors asso-
ciated with good outcomes. They recently analyzed 10
years of data from 240 babies who were treated at 25 cen-
ters, allowing them to address, for example, whether the
donor source or the use of a pretransplantation condition-
ing regimen influenced outcomes. The results highlight
the benefits of transplantation before 3.5 months of age
and before the baby has had an infection, a scenario that
is more likely with newborn screening (NBS). For those
regions without NBS for SCID, the data can inform the
treatment approach; they indicate that treatment of infec-
tion prior to transplantation, if possible, is associated with
better outcomes.
Pai et al. (2014). N. Eng. J. Med. 371, 434–446.
Two Aren’t Always Better Than One
Despite their success in some patients, the newest drugs for
treating cystic fibrosis (CF), such as Kalydeco, are ineffec-
tive in the vast majority of people with CF. These drugs
act on the CFTR channel at the cell surface, but the most
common variant in CFTR, p.Phe508del (DF508), never
makes it there and thus prevents the channel potentiator
from acting. Other new drugs are so-called correctors that
are designed to improve proper processing and localization
of altered CFTR; however, they have proved less potent
than hoped in clinical trials. This led to the idea that com-
binations of drugs—one corrector drug to help the protein
reach the cell surface and one potentiator to help the
channel work once it gets there—might be needed to
help patients with DF508. Unfortunately, combination
clinical trials have so far had disappointing results in these
patients, although the reason was initially unclear. Two
recent papers have a surprising explanation. Potentiators,
which should simply help open the CFTR channel, can
actually alter the level of the channel on the cell surface.
In respiratory epithelial cells with DF508, both groups
demonstrated that chronic administration of a potentiator
counteracted the corrector drug, impairing presentation
of CFTR at the cell surface by influencing its turnover
and stability. This effect was mutation dependent and1Department of Human Genetics, Emory University School of Medicine, Atlan
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The Americanwas not observed with p.Gly551Asp (G551D), the substitu-
tion Kalydeco was originally approved to treat.
Cholon et al. (2014). Sci. Transl. Med. 6, 246ra96.
Veit et al. (2014). Sci. Transl. Med. 6, 246ra97.
Using Founder Effects to an Advantage
The excess of very rare variation in the human population
impedes the interpretation of sequence variation—how do
you assess variant outcome in a sample of one? And how
do you collect a group of people with the same variant if
you don’t know what their phenotype is going to be? To
get around these challenges, Lim et al. started with a pop-
ulation that is somewhat unusual: the Finnish population.
Because this group is a historically isolated population that
has undergone a bottleneck, the researchers surmised that
there would be an enrichment of low-frequency variants,
and exome sequences from 3,000 Finns supported this
assertion. This sequence information helped them find
enough people with the same variant to study its outcome.
In conjunction with phenotype information from Finnish
National Health Registers, the effects of 83 loss-of-function
variants were assessed. Finding individuals homozygous
for mutations in specific genes also allowed this group to
argue against the role of the genes in Mendelian disease,
despite the fact that some of them were found in OMIM.
Lim et al. (2014). PLOS Genet. 10, e1004494.
A Different View
Certainly noninvasive prenatal tests (NIPTs) based on the
analysis of cell-free fetal DNA are an advance in prenatal-
screening technology. They have been touted for their
increased sensitivity, which is much better than that of
screens based on maternal serum markers. Wang et al.
remind us that we should also keep in mind their false-
positive rates. The authors assessed cytogenetic con-
firmation after positive NIPTs and found that false-positive
rates ranged from 7% for trisomy 21 to 62% for sex
chromosome aneuploidy, which should serve as a
reminder that this approach is still a screen and not yet a
diagnostic test.
Wang et al. (2014). Genet. Med. Published online August 7,
2014. http://dx.doi.org/10.1038/gim.2014.92.
Transgenerational Inheritance after Starvation
Studies including the Dutch famine birth cohort indi-
cate that malnutrition has long-lasting effects onta, GA 30322, USA
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metabolism and health. Long-lasting might be some-
thing of an understatement, given that some of these
effects can be observed even in the children and grand-
children of malnourished individuals. An epigenetic
mechanism is suspected by some, but its exact nature is
unknown, and this proposal has been controversial.
Now, Rechavi et al. have described, in C. elegans, star-
vation-induced transgenerational inheritance of small
RNAs that target endogenous genes, including some244 The American Journal of Human Genetics 95, 243–244, Septembinvolved in regulating nutrient reservoirs. F3 worms
from the starved generation exhibited altered expres-
sion patterns for many of these target genes and also
had a 30% longer lifespan. Whether the same epige-
netic mechanism holds true in humans is anybody’s
guess, but this work provides more concrete evidence of
transgenerational inheritance that influences endoge-
nous pathways.
Rechavi et al. (2014). Cell 158, 277–287.This Month in Our Sister JournalsLD Profiles from Individuals
Traditional measures of linkage disequilibrium (LD) from
population samples are generally applied to a limited
number of genetic markers that have at least an intermedi-
ate allele frequency. The availability of whole-genome
sequencing data provides the raw data for branching out
beyond this type of approach, which is exactly what Lynch
et al. have attempted. Their analysis of the distribution of
heterozygous sites in individual genomes yielded informa-
tive patterns of LD as a function of physical distance. Their
proposed statistic, the correlation of zygosity, is closelyrelated to population measures of LD but is less prone to
certainoutlier artifacts. Its application to the genomesofhu-
mansandother vertebrates indicates that geneconversion is
a commonmechanism for resolving recombination events.
These conversion events generally encompass hundreds to
thousands of base pairs, and contrary to assumptions that
are often made in population analyses, Lynch et al. suspect
that rates of recombination between neighboring sites are
much higher than expected given the sites’ proximity.
Lynch et al. (2014). Genetics. Published online June 19,
2014. http://dx.doi.org/10.1534/genetics.114.166843.er 4, 2014
